To learn more about Cleveland Clinic’s Pericardial Disease Center, please visit [ Ссылка ]
Patients with pericarditis may be on various medications to prevent episodes from recurring. Dr. Allan Klein, Director of Cleveland Clinic’s Pericardial Disease Center, provides the results of the RHAPSODY trial that looked at a new medication (Rilonacept) vs. placebo for patients with pericarditis. He talks about the exciting results of this study and what this may mean for patients in the future.
Read the full article at Klein AL, Imazio M, Cremer P, et al., on behalf of the RHAPSODY Investigators. Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. N Engl J Med 2020; Nov 16: [ Ссылка ]
▶Share this video with others: [ Ссылка ]
▶Subscribe to learn more about Cleveland Clinic: [ Ссылка ]
Recurrent Pericarditis: New Treatment Shows Promise
Теги
pericarditistreatment of pericarditisrilonaceptchest painclinical trialresearchcleveland cliniccleveland clinic studyrilonacept and pericarditisacute pericarditis treatmentacute pericarditisrecurrent pericarditispericardial diseasepericarditis treatmentcleveland clinic researchallan klein mdrhapsody trialdr. allan kleincleveland clinic clinical trialsheart research
